Separation Systems For Commercial Biotechnology Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 24.91 Billion |
| Market Size (2029) | USD 30.51 Billion |
| CAGR (2024 - 2028) | 4.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Separation Systems For Commercial Biotechnology Market Analysis
The Separation Systems For Commercial Biotechnology Market size is estimated at USD 24.91 billion in 2024, and is expected to reach USD 30.51 billion by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).
- The major factor contributing to the market's growth is the increasing advancement of cell separations and the growing demand for biopharmaceuticals. For instance, in November 2022, Sony Corporation launched the SFA - Life Sciences Cloud Platform. This flow cytometry data analysis cloud solution can quickly identify rare cells, such as cancer and stem cells, from various cell populations using data obtained from flow cytometers.
- Similarly, in September 2022, Tosoh Bioscience GmbH, a provider of chromatographic solutions for the separation and purification of biomolecules, launched the Octave BIO multi-column chromatography (MCC) system. This system, combined with the SkillPak BIO pre-packed columns, enables customers to develop pre-clinical processes quickly and efficiently. Thus, developing such innovative cloud platforms and launching various chromatography systems are expected to augment the demand for separation systems, contributing to the market growth during the forecast period.
- Moreover, research studies involving the recent advancement of cell separation are expected to drive market growth. For instance, as per the article published in January 2022 in MDPI, magnetic cell separation has emerged as a critical technology for isolating specific cell populations from biological suspensions, with applications ranging from diagnosis and therapy in biomedicine to environmental applications or fundamental research in biology. Hence, owing to the increase in advantages offered by separation systems, the market is expected to witness significant growth during the forecast period.
- Thus, due to the increase in product launches and advancements in cell separation in biotechnology, the separation systems for the commercial biotechnology market are expected to witness significant growth during the forecast period. However, the high cost of research and development will likely restrain market growth.
Separation Systems For Commercial Biotechnology Market Trends
The Biopharmaceutical Segment is Anticipated to Witness a Growth During the Forecast Period
- In the biopharmaceutical field, the separation stage is applied to remove unwanted by-products from API manufacturing, and the most used technologies are chromatography, nanofiltration, ultrafiltration, sublimation, de-sublimation, distillation, and crystallization. The biopharmaceutical segment is expected to witness significant market growth owing to the increased demand for personalized medicines and cell-based therapies and advancements in the biopharmaceutical industry.
- For instance, in November 2022, Alfa Laval launched a new multipurpose membrane filtration system that can be seamlessly connected to up and downstream operations. It increases flexibility across a range of process applications. This includes the purification of proteins, sugar, and starch, the concentration of peptides and amino acid streams, and water recovery from condensates.
- Moreover, according to the article published in September 2022 in London, identifying a molecule with therapeutic potential is the initial step in developing a medicine, after which molecules such as drug candidates are examined for metabolism and pharmacokinetics. Because of their great sensitivity and selectivity, these chemicals are routinely tested using combination techniques such as liquid chromatography-mass spectrometry (LC-MS) or LC-MS/MS.
- Also, an increase in biopharmaceutical plants across the globe is likely to increase the utilization of separation systems. For instance, in May 2022, INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, opened a biomanufacturing facility in Indiana.
- Hence, due to the increase in product launches and advancements in cell separation in biotechnology, the biopharmaceutical segment is expected to witness significant growth during the forecast period.
North America Anticipated to Hold a Significant Share in the Market During the Forecast Period
- North America is expected to hold a significant market share during the forecast period due to factors such as the presence of key players, increased research activities utilizing the separation systems, and established healthcare infrastructure. Also, beneficial government initiatives and increased research partnerships are some drivers expected to increase market growth.
- For instance, as per the NIH 2022 update, the estimated research funding for biotechnology was USD 8,142 million in 2022. Hence, such high investments by the government are likely to drive market growth.
- Moreover, establishing pharmaceutical companies focusing on endocrinology is expected to boost the demand for separation systems for commercial biotechnology during the forecast period. For instance, in January 2024, Redesign Health launched healthcare startups and secured a substantial USD 4 million seed funding. Their latest venture aims to enhance diabetes care. Diabetes is a complex condition that presents challenges for both patients and puts significant stress on endocrinology practices.
- Hence, due to the increase in advancements in separation systems and the rise in research funding, North America is expected to hold a significant market share during the forecast period.
Separation Systems For Commercial Biotechnology Industry Overview
The separation systems for the commercial biotechnology market are moderately competitive and consist of several major players. Currently, major players are founding strategic partnerships with other entities and collaborating to enhance their product portfolios in the field of separation systems to develop technologically advanced systems. Some of the companies that are currently dominating the market are Perkin Elmer Inc., Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Shimadzu Corporation, bioMérieux SA, Agilent Technologies, and Bio-Rad Laboratories Inc.
Separation Systems For Commercial Biotechnology Market Leaders
-
Perkin Elmer, Inc.
-
Sartorius AG
-
Thermo Fisher Scientific, Inc.
-
Merck KGaA
-
Becton, Dickinson and Company
*Disclaimer: Major Players sorted in no particular order
Separation Systems For Commercial Biotechnology Market News
- February 2023: Bio-Rad Laboratories Inc. launched the StarBright Blue-series and StarBright Yellow-series Dyes to provide greater flexibility in conventional and full-spectrum flow cytometry applications. The dyes enhance research capabilities across the blue (488 nm) and yellow (561 nm) lasers by providing outstanding brightness with narrow excitation and emission patterns for accurate resolution.
- January 2023: METAFORA Biosystems launched METAflow, its digital flow cytometry platform, in the European and United States markets. METAflow provides a sophisticated unsupervised algorithm suite through a user-friendly workflow. Despite data processing expertise, METAflow is a cloud-based software enabling automated multidimensional flow cytometry data clustering.
Separation Systems For Commercial Biotechnology Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advances in Cell Separation Techniques and Rising Demand for Cell-based Therapies
4.2.2 Rise in Government and Private Funding
4.3 Market Restraints
4.3.1 High Cost Involved in Research and Development
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Methods
5.1.1 Mordern Methods
5.1.1.1 Microarray
5.1.1.2 Lab-on-a-chip
5.1.1.3 Magnetic separation
5.1.1.4 Other Modern Methods
5.1.2 Conventional Methods
5.1.2.1 Chromatography
5.1.2.2 Flow Cytometry
5.1.2.3 Membrane Filtration
5.1.2.4 Other Conventional Methods
5.2 By Application
5.2.1 Biopharmaceutical
5.2.2 Food and Cosmetics
5.2.3 Agriculture
5.2.4 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Perkin Elmer Inc.
6.1.2 Sartorius AG
6.1.3 Thermo Fisher Scientific Inc.
6.1.4 Merck KGaA
6.1.5 Becton, Dickinson and Company
6.1.6 Shimadzu Corporation
6.1.7 bioMerieux SA
6.1.8 Agilent Technologies
6.1.9 Bio-Rad Laboratories Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Separation Systems For Commercial Biotechnology Industry Segmentation
Separation systems purify biological products such as biopharmaceuticals, biochemicals, and diagnostic reagents depending on the electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment that separates biological material from complex mixtures or solutions includes chromatography, membranes or filters, and centrifuges.
The separation systems for the commercial biotechnology market are segmented by method, application, and geography. By method, the market is segmented into modern methods and conventional methods. By application, the market is segmented as biopharmaceutical, food and cosmetics, agriculture, and other applications. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across the major regions globally.
The report offers the value (USD) for all the above segments.
| By Methods | ||||||
| ||||||
|
| By Application | |
| Biopharmaceutical | |
| Food and Cosmetics | |
| Agriculture | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Separation Systems For Commercial Biotechnology Market Research FAQs
How big is the Separation Systems For Commercial Biotechnology Market?
The Separation Systems For Commercial Biotechnology Market size is expected to reach USD 24.91 billion in 2024 and grow at a CAGR of 4.20% to reach USD 30.51 billion by 2029.
What is the current Separation Systems For Commercial Biotechnology Market size?
In 2024, the Separation Systems For Commercial Biotechnology Market size is expected to reach USD 24.91 billion.
Who are the key players in Separation Systems For Commercial Biotechnology Market?
Perkin Elmer, Inc., Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA and Becton, Dickinson and Company are the major companies operating in the Separation Systems For Commercial Biotechnology Market.
Which is the fastest growing region in Separation Systems For Commercial Biotechnology Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Separation Systems For Commercial Biotechnology Market?
In 2024, the North America accounts for the largest market share in Separation Systems For Commercial Biotechnology Market.
What years does this Separation Systems For Commercial Biotechnology Market cover, and what was the market size in 2023?
In 2023, the Separation Systems For Commercial Biotechnology Market size was estimated at USD 23.86 billion. The report covers the Separation Systems For Commercial Biotechnology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Separation Systems For Commercial Biotechnology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Separation Systems For Commercial Biotechnology Industry Report
Statistics for the 2024 Separation Systems For Commercial Biotechnology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Separation Systems For Commercial Biotechnology analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
